Makers of Wegovy & Zepbound Cut Prices for Those Without Insurance
By I. Edwards HealthDay Reporter
FRIDAY, March 7, 2025 -- The makers of two popular weight-loss drugs — Wegovy and Zepbound — are cutting prices to make the medications more affordable for people without insurance.
Novo Nordisk, the Danish company behind Wegovy, announced Wednesday that it has lowered its monthly cost by 23%. The new price -- $499 per month -- takes effect immediately. It had been $650 a month.
The discount applies to all dose levels of the medication, NBC News reported.
The lower price is available to both uninsured patients and people whose insurance does not cover weight-loss drugs, the company also said.
Last week, Eli Lilly, the maker of Zepbound, also cut prices for its starter dose to $349 per month.
Larger doses will now cost $499 per month through the company's self-pay program.
People using these GLP-1 meds start with smaller doses and gradually increase to higher amounts over time.
The price cuts come as supply issues ease. Both medications have recently been removed from the U.S. Food and Drug Administration's shortage list, allowing the companies to meet growing demand.
As a result, compounding pharmacies, which were allowed to make off-brand versions during the shortage, will need to wind down production.
Both Wegovy and Zepbound belong to a class of drugs that have been shown to help people lose weight by reducing appetite and increasing the feelings of fullness.
Sources
- NBC News, March 5, 2025
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2025 HealthDay. All rights reserved.
Posted March 2025
Read this next
Number Of Family Caregivers Has Skyrocketed in The U.S.
FRIDAY, July 25, 2025 — The number of Americans caring for an older or disabled family member has risen dramatically during the past 10 years, according to a new AARP policy...
Vitamin D Might Offer Protection Against COVID-19
FRIDAY, July 25, 2025 — Low vitamin D levels might increase a person’s odds of a severe bout with COVID-19, a new study says. People with a vitamin D deficiency are...
For the Win: College Student Powerlifts Past Breast Cancer
FRIDAY, July 25, 2025 — LaShae Rolle, 27, is a competitive powerlifter capable of squatting 441 pounds, benching 292 pounds and deadlifting 497 pounds. Last year, breast...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.